Current Drug Targets
Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Ranking and Category
-
131st of 267 in
Pharmacology & Pharmacy
  |
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research
Contents
Current Drug Targets, Volume 16 - Number 7
Is there a Role for Bevacizumab in Non-Glial Tumors?
, 16(7): 684 - 688Elisa Trevisan, Luca Bertero, Michela Magistrello, Roberta Ruda and Riccardo Soffietti
DOI: 10.2174/1389450116666150325230810
Is there a Role for Bevacizumab in Non-Glial Tumors?
Mechanisms of bacterial acetohydroxyacid synthase (ahas) and specific inhibitors of Mycobacterium tuberculosis ahas as potential drug candidates against tuberculosis
, 16(7): 689 - 699Kunal Gokhale and Bhargav Tilak
DOI: 10.2174/1389450116666150416115547
Mechanisms of bacterial acetohydroxyacid synthase (ahas) and specific inhibitors of Mycobacterium tuberculosis ahas as potential drug candidates against tuberculosis
Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation
, 16(7): 700 - 710Erin E. Witalison, Paul R. Thompson and Lorne J. Hofseth
DOI: 10.2174/1389450116666150202160954
Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation
Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
, 16(7): 711 - 734Imran Ali, Mohammad Nadeem Lone, Zeid A. Al-Othman, Abdulrahman Al-Warthan and Mohd. Marsin Sanagi
DOI: 10.2174/1389450116666150309115922
Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Selective Modulators of α5-Containing GABAA Receptors and their Therapeutic Significance
, 16(7): 735 - 746Ming Shiuan Soh and Joseph W. Lynch
DOI: 10.2174/1389450116666150309120235
Selective Modulators of α5-Containing GABAA Receptors and their Therapeutic Significance
Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions
, 16(7): 747 - 756Francesca Scicchitano, Andrew Constanti, Rita Citraro, Giovambattista De Sarro and Emilio Russo
DOI: 10.2174/1389450116666150330114850
Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions
Steps and Routes of HCV Infection: The Great Promise of New Anti-Viral Targets
, 16(7): 757 - 770Annalisa Crema, Antonio Ponzetto, Massimo Clementi and Guido Carloni
DOI: 10.2174/1389450116666150213111603
Steps and Routes of HCV Infection: The Great Promise of New Anti-Viral Targets
Role of Free Fatty Acid Receptor 2 (FFAR2) in the Regulation of Metabolic Homeostasis
, 16(7): 771 - 775Sameer Mohammad
DOI: 10.2174/1389450116666150408103557
Role of Free Fatty Acid Receptor 2 (FFAR2) in the Regulation of Metabolic Homeostasis
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Advertisement
Webmaster Contact: info@benthamscience.net